Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 16.

Djalali, S; Hasse, B; Senn, O (2016). Mehr Hausarztmedizin für HIV-Patienten. Primary and Hospital Care, 16(16):296-297.

Swiss HIV Cohort Study; Kouyos, R D; Hasse, B; et al (2015). Increases in condomless sex in the swiss HIV cohort study. Open Forum Infectious Diseases, 2(2):1-4.

Hasse, B; Iff, M; Ledergerber, B; et al; Böni, J (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV cohort study. Open Forum Infectious Diseases, 1(2):ofu040.

El Amari, E B; Combescure, C; Yerly, S; Calmy, A; Kaiser, L; Hasse, B; Furrer, H; Cavassini, M; Vernazza, P; Hirsch, H H; Bernasconi, E; Hirschel, B (2011). Clinical relevance of cytomegalovirus viraemia(*,†). HIV Medicine, 12(7):394-402.

Meier, S; Weber, R; Zbinden, R; Ruef, C; Hasse, B (2011). Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection, 39(4):333-340.

Magenta, L; Dell-Kuster, S; Richter, W O; Young, J; Hasse, B; Flepp, M; Hirschel, B; Vernazza, P; Evison, J; Cavassini, M; Decosterd, L A; Bucher, H C; Bernasconi, E (2011). Lipid and lipoprotein profile in HIV-infected patients treated with Lopinavir/Ritonavir as a component of the first combination antiretroviral therapy. AIDS Research and Human Retroviruses, 27(5):525-533.

Mayer, D; Hasse, B; Koelliker, J; Enzler, M; Veith, F J; Rancic, Z; Lachat, M (2011). Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Annals of Surgery, 254(5):754-759; discussion 760.

Hasse, B; Ledergerber, B; Furrer, H; Battegay, M; Hirschel, B; Cavassini, M; Bertisch, B; Bernasconi, E; Weber, R (2011). Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clinical Infectious Diseases, 53(11):1130-1139.

Hasse, B; Ledergerber, B; Hirschel, B; Vernazza, P; Glass, T R; Jeannin, A; Evison, J M; Elzi, L; Cavassini, M; Bernasconi, E; Nicca, D; Weber, R (2010). Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clinical Infectious Diseases, 51(11):1314-1322.

Kuster, S P; Hasse, B; Huebner, V; Bansal, V; Zbinden, R; Ruef, C; Ledergerber, B; Weber, R (2010). Risks factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care university hospital in Switzerland. Infection, 38(1):33-40.

Keiser, O; Spoerri, A; Brinkhof, M W G; Hasse, B; Gayet-Ageron, A; Tissot, F; Christen, A; Battegay, M; Schmid, P; Bernasconi, E; Egger, M (2010). Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008. American Journal of Psychiatry, 167(2):143-150.

Scherrer, A U; Hasse, B; von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Bucher, H C; Ledergerber, B; Günthard, H F (2009). Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS). HIV Medicine, 10(10):647-656.

Polesel, J; Clifford, G M; Rickenbach, M; Dal Maso, L; Battegay, M; Bouchardy, C; Furrer, H; Hasse, B; Levi, F; Probst-Hensch, N M; Schmid, P; Franceschi, S (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2):301-306.

Franceschi, S; Polesel, J; Rickenbach, M; Dal Maso, L; Probst-Hensch, N M; Fux, C; Cavassini, M; Hasse, B; Kofler, A; Ledergerber, B; Erb, P; Clifford, G M (2006). Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study. British Journal of Cancer, 95(11):1598-1602.

Aceto, L; Karrer, U; Grube, Ch; Oberholzer, R; Hasse, B; Presterl, E; Böni, J; Kuster, H; Trkola, A; Weber, R; Günthard, H F (2005). Die akute HIV-1-Infektion in Zürich: 2002–2004. Praxis, 94(32):1199-1205.

Hasse, B; Hummel, Y; Böni, J; Schüpbach, J; Flepp, M; Günthard, H F (2003). 25-jähriger therapienaiver Patient mit einem dreiklassenresistenten HI-Virus. Praxis, 92(13):601-605.

This list was generated on Thu Oct 19 11:34:21 2017 CEST.